• LAST PRICE
    13.1650
  • TODAY'S CHANGE (%)
    Trending Up0.0050 (0.0380%)
  • Bid / Lots
    13.1600/ 11
  • Ask / Lots
    13.1700/ 4
  • Open / Previous Close
    13.1800 / 13.1600
  • Day Range
    Low 13.1300
    High 13.2000
  • 52 Week Range
    Low 2.3150
    High 13.6000
  • Volume
    425,010
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 13.16
TimeVolumeAKUS
09:32 ET268113.1564
09:33 ET128313.18
09:35 ET10013.2
09:39 ET139713.17
09:46 ET1101713.17
09:48 ET1785213.16
09:50 ET30013.16
09:51 ET405013.155
09:53 ET30013.155
09:55 ET450913.16
09:57 ET284013.16
10:00 ET463513.165
10:02 ET50013.165
10:04 ET500013.165
10:06 ET310013.165
10:08 ET80013.17
10:09 ET130013.17
10:11 ET114813.17
10:13 ET20013.17
10:15 ET60013.165
10:18 ET110013.17
10:20 ET1201713.165
10:22 ET99913.17
10:24 ET100013.165
10:26 ET91613.16
10:27 ET60013.165
10:29 ET1451813.165
10:31 ET20013.165
10:33 ET30013.165
10:36 ET80013.165
10:38 ET30013.165
10:40 ET130013.165
10:42 ET50013.165
10:44 ET20013.165
10:45 ET183513.165
10:47 ET60813.16
10:49 ET210813.165
10:51 ET1487313.165
10:54 ET1086613.165
10:56 ET40013.16
10:58 ET787213.15
11:00 ET508613.155
11:02 ET120013.155
11:03 ET20013.155
11:05 ET435013.16
11:07 ET90013.155
11:09 ET90013.155
11:12 ET168013.16
11:14 ET100013.15
11:16 ET100013.15
11:18 ET90013.155
11:20 ET51813.15
11:21 ET150013.155
11:23 ET220013.15
11:25 ET60013.15
11:27 ET120013.16
11:30 ET266013.15
11:32 ET40013.15
11:34 ET402713.155
11:36 ET180013.15
11:38 ET157513.15
11:39 ET3162313.16
11:41 ET7240013.145
11:43 ET3402213.135
11:45 ET40013.135
11:48 ET230013.135
11:50 ET2448913.15
11:52 ET462313.165
11:54 ET187513.15
11:56 ET152513.16
11:59 ET40013.155
12:01 ET332213.16
12:06 ET100013.155
12:08 ET294813.17
12:10 ET30013.165
12:12 ET70013.165
12:14 ET2137513.16
12:17 ET30013.165
12:19 ET250013.1625
12:21 ET433013.165
12:24 ET40013.16
12:26 ET20013.165
12:28 ET1153013.17
12:30 ET160013.175
12:32 ET129213.165
12:33 ET120013.17
12:35 ET210013.165
12:37 ET20013.165
12:39 ET30013.165
12:42 ET60013.165
12:44 ET110013.165
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesAKUS
Akouos Inc
486.2M
-5.0x
---
United StatesMLTX
MoonLake Immunotherapeutics
478.5M
-6.9x
---
United StatesINO
Inovio Pharmaceuticals Inc
474.0M
-1.3x
---
United StatesKZR
Kezar Life Sciences Inc
506.0M
-7.4x
---
United StatesBCAB
Bioatla Inc
466.1M
-3.8x
---
United StatesCMPX
Compass Therapeutics Inc.
512.3M
-10.0x
---
As of 2022-11-29

Company Information

Akouos Inc. precision genetic medicine company focused on developing gene therapies with the potential to restore, improve, and preserve high-acuity physiologic hearing for individuals. The Company is focused on developing precision therapies for forms of sensorineural hearing loss. The Company's genetic medicine platform that incorporates a proprietary vector library consisting of variants of a small virus commonly used in gene therapy, known as adeno-associated virus (AAV), and a novel delivery approach. The Company is focused on executing its initiatives, which include the advancement of its lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene; expansion of its pipeline to include programs focused on other monogenic conditions as well as inner ear conditions of complex etiology, such as AK-antiVEGF for vestibular schwannoma; and development of internal manufacturing capabilities, and a commercial infrastructure.

Contact Information

Headquarters
645 SUMMER STREET, SUITE 200BOSTON, MA, United States 02210
Phone
857-410-1818
Fax
302-655-5049

Executives

Independent Chairman of the Board
Arthur Tzianabos
President, Chief Executive Officer, Co-Founder, Director
Emmanuel Simons
Co-Founder, Chief Medical Officer
Michael Mckenna
Chief Financial Officer
Sachiyo Minegishi
Chief Operating Officer
Jennifer Wellman

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$486.2M
Revenue (TTM)
$0.00
Shares Outstanding
36.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.62
Book Value
$6.77
P/E Ratio
-5.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.